Added to YB: 2025-02-03
Pitch date: 2025-01-31
CRGX [bullish]
CARGO Therapeutics, Inc.
+27.71%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States.
Market Cap
$215.7M
Pitch Price
$3.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.32
P/E
-0.96
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
CARGO Therapeutics: Broken Biotech, Significant Cash Position
CRGX: Phase 2 study discontinued due to poor risk-benefit profile, stock -75%. 50% workforce reduction, strategic review initiated. $150M market cap vs significant cash balance. Phase 1 asset CRG-023 IND approved. Potential reverse merger target. Added to broken biotech basket.
Read full article (1 min)